Science China Life Sciences

, Volume 62, Issue 3, pp 433–434 | Cite as

An improved protocol for the treatment of fulminant myocarditis

  • Matthew L. Edin
  • Darryl C. ZeldinEmail author
News and Views



This work was supported, in part, by the Division of Intramural Research, National Institute of Environmental Health Sciences, NIH (Z01 ES025034 to D.C.Z.).


  1. Caldeira, D., Lopes, L.R., Vaz-Carneiro, A., and Costa, J. (2015). Cochrane Corner–administração de corticosteroides para miocardite de etiologia viral. Revista Portuguesa de Cardiologia 34, 65–67.CrossRefGoogle Scholar
  2. Li, S., Xu, S., Li, C., Ran, X., Cui, G., He, M., Miao, K., Zhao, C., Yan, J., Hui, R., et al. (2019). A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: a multiple center study. Sci China Life Sci 62, doi: 10.1007/s11427-018-9501-9.Google Scholar
  3. McCarthy, R.E., Boehmer, J.P., Hruban, R.H., Hutchins, G.M., Kasper, E. K., Hare, J.M., and Baughman, K.L. (2000). Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342, 690–695.CrossRefGoogle Scholar
  4. Robinson, J., Hartling, L., Vandermeer, B., and Klassen, T.P. (2015). Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst Rev 20, CD004370.Google Scholar
  5. Wang, D., Li, S., Jiang, J., Yan, J., Zhao, C., Wang, Y., Ma, Y., Zeng, H., Guo, X., Wang, H., et al. (2019). Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis. Sci China Life Sci 62, 187–202.CrossRefGoogle Scholar

Copyright information

© Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Intramural Research, National Institute of Environmental Health SciencesNational Institutes of HealthResearch Triangle ParkUSA

Personalised recommendations